Chris Doran

Chris Doran has a diverse work experience in the pharmaceutical and healthcare industry. Chris is currently working as the Director of Key Accounts - Florida at Coherus BioSciences since January 2022. Prior to this role, they served as a Senior Oncology Account Manager at the same company from March 2021 to January 2022. Before joining Coherus BioSciences, Chris worked at Octapharma as a Senior Territory Business Manager - Oncology/Immunology from October 2014 to October 2018. Chris was responsible for achieving sales goals for Octagam IVIG in various healthcare settings. Previously, Chris worked at Myriad Genetics as a Urology/Oncology Account Executive from February 2013 to October 2014, where they achieved sales goals for Prolaris. Chris also worked at Endo Pharmaceuticals (formerly Indevus Pharmaceuticals) as a Senior Urology/Oncology Sales Specialist from July 2004 to October 2012, where they played a vital role in the launch and promotion of several products. Chris started their career at Pharmacia Corporation (formerly Searle Pharmaceuticals) in 1992, where they progressed through various positions and participated in product launches.

Chris Doran has a Bachelor of Business Administration (B.B.A.) degree in Marketing from Valdosta State University.